Broker's Call: Glenmark Life Sciences (Buy)
Anand Rathi Research21-11-2022
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investors Presentation - Glenmark Life Sciences Limited Investor Day 202217-11-2022
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Investor Presentation
Further to our communication dated November 11, 2022, attached is a copy of the presentation to be made at Glenmark Life Sciences Limited - Investor Day 2022 which is scheduled today at 15:45 IST in Mumbai. Kindly take the same on record and acknowledge receipt.17-11-2022
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Pursuant to Regulation 32(6) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 read with Regulation 41(4) of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, we are enclosing herewith Monitoring Agency Report issued by HDFC Bank Limited, Monitoring Agency, for the quarter ended 30th September, 2022 in respect of utilization of proceeds of the IPO of the Company. This is for your information and record.14-11-2022
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
This is to inform you that Glenmark Life Sciences Limited will host an 'Investor Day' from 15:45 to 17:15 IST on Thursday, November 17, 2022, in Mumbai. The Senior Management team of Glenmark Life Sciences will be presenting the Company's growth plans to investors and research firms. The presentation material for the event will be disseminated to the Stock Exchanges and uploaded on the Company's website closer to the event. This is for your information and records.11-11-2022
Glenmark Life Sciences Ltd - 543322 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
In Compliance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosure of Related Party Transactions for the half year ended September 30, 2022. Request you to kindly take the same on record.04-11-2022
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Pursuant to Regulation 30(6) read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the transcript of the Earnings call held on Friday, October 21, 2022 for the quarter and half year ended September 30, 2022 is available on the Company's website at: https://www.glenmarklifesciences.com/pdf/Transcript%20of%20Earnings%20Concall%20Q2%20FY2022-23.pdf The said transcript is also attached.27-10-2022
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Pursuant to the Regulation 30 and 46 read with Part A of Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of the Q2 FY2022-23 Earnings Call held on 21st October, 2022 on the website of the Company at: https://www.glenmarklifesciences.com/pdf/GLE9320221021143558.mp3 Request you to kindly take the same on record.22-10-2022
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Change in Management
Outcome of Board Meeting - Changes to the Board21-10-2022
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the investor presentation.21-10-2022